Sanna Sillankorva

Sanna Sillankorva is a Principal Investigator at the International Iberian Nanotechnology Laboratory (INL) in Braga, Portugal, focusing on nanomedicine and life sciences. Previously, she held roles as Assistant Researcher and Postdoctoral Researcher at the Universidade do Minho, where she completed her PhD (2009) and MSc (2004) in Chemical/Biological Engineering and Environmental Technologies respectively.

• Current Role: PI at INL's Nano4Health program
• Research Focus: Bacteriophage applications in biofilm control, antimicrobial delivery systems, and nanotechnology-based medical solutions
• Key Projects: Development of phage-loaded microneedles, phage-encapsulated films, and biofilm-targeted therapies

Her work spans over 165 publications, with recent emphasis on phage therapy, biomaterials, and One Health approaches to combat antibiotic resistance. She has secured funding from institutions like FCT (Portugal) and the European Commission, totaling over 15 grants since 2000.

Notable contributions include engineering phage-based treatments for chronic wounds, otitis media, and foodborne pathogens, leveraging nanotechnology for enhanced drug delivery and biofilm eradication.